February 10, Aldevron hosted a virtual celebration of its lab facility expansion in Madison.
Aldevron produces the raw materials that allow clients to make groundbreaking therapies, and its protein business unit has operated within University Research Park since 2009. The facility’s growth from 8,000 to nearly 30,000 square feet includes a new 3,500-square-foot fermentation suite and will allow the company to expand its projects’ scope and scale.
Aldevron founders John Ballantyne and Michael Chambers partnered with Tom Foti to establish the company’s protein business unit in Madison in 2009 to expand Aldevron’s offerings.
“Madison is rightly known around the world as a biotech hotspot, and the fact that there was a team out there ready to hit the ground running made it sort of a no-brainer,” said Ballantyne, who serves as Aldevron’s Chief Science Officer.